|
EP1351691A4
(en)
|
2000-12-12 |
2005-06-22 |
Cytovia Inc |
SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF
|
|
AU2003262642B2
(en)
|
2002-08-14 |
2010-06-17 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
US20060281763A1
(en)
|
2005-03-25 |
2006-12-14 |
Axon Jonathan R |
Carboxamide inhibitors of TGFbeta
|
|
US7517882B2
(en)
|
2006-09-18 |
2009-04-14 |
Polaris Group |
Protein kinase inhibitors
|
|
KR20100132550A
(ko)
|
2008-04-16 |
2010-12-17 |
포톨라 파마슈티컬스, 인코포레이티드 |
syk 또는 JAK 키나제 억제제로서의 2,6-디아미노-피리미딘-5-일-카르복스아미드
|
|
EP2361902A4
(en)
|
2008-11-21 |
2012-04-25 |
Astellas Pharma Inc |
4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
|
|
MX2011011875A
(es)
|
2009-05-08 |
2011-12-08 |
Astellas Pharma Inc |
Compuesto de carboxamida heterociclica diamino.
|
|
BR122019024201B1
(pt)
|
2010-05-20 |
2021-08-03 |
Array Biopharma Inc |
Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica
|
|
EP2975027A1
(en)
|
2010-11-01 |
2016-01-20 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as jak kinase modulators
|
|
AU2011323484B2
(en)
|
2010-11-01 |
2016-10-06 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as Syk modulators
|
|
CN102250065B
(zh)
|
2011-05-20 |
2015-05-13 |
浙江海正药业股份有限公司 |
取代的三嗪苯脲衍生物及其用途
|
|
WO2013001310A1
(en)
|
2011-06-30 |
2013-01-03 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Macrocyclic compounds and their use as cdk8 inhibitors
|
|
PT2760453T
(pt)
|
2011-09-30 |
2016-08-02 |
Ipsen Pharma Sas |
Inibidores macrocíclicos da cinase lrrk2
|
|
KR20140108594A
(ko)
|
2012-01-10 |
2014-09-11 |
에프. 호프만-라 로슈 아게 |
피리다진 아미드 화합물 및 syk 저해제로서의 이의 용도
|
|
HRP20220766T1
(hr)
|
2012-11-08 |
2022-09-16 |
Bristol-Myers Squibb Company |
Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora
|
|
US9701689B2
(en)
|
2012-11-30 |
2017-07-11 |
Kyowa Hakko Kirin Co., Ltd. |
Substituted pyridines and pyridazines as CCR10 receptor inhibitors
|
|
WO2014140299A1
(en)
|
2013-03-15 |
2014-09-18 |
Oncodesign S.A |
Macrocyclic rip2 kinase inhibitors
|
|
JP6484555B2
(ja)
|
2013-08-29 |
2019-03-13 |
京都薬品工業株式会社 |
新規芳香族化合物およびその用途
|
|
AR094537A1
(es)
|
2013-11-07 |
2015-08-12 |
Bristol Myers Squibb Co |
COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa
|
|
AU2014360446A1
(en)
|
2013-12-05 |
2016-06-09 |
Pharmacyclics, Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
WO2015112806A2
(en)
|
2014-01-24 |
2015-07-30 |
Tp Therapeutics, Inc. |
Diaryl macrocycles as modulators of protein kinases
|
|
WO2015123453A1
(en)
|
2014-02-14 |
2015-08-20 |
Portola Pharmaceuticals, Inc. |
Pyridazine compounds as jak inhibitors
|
|
CN105111151B
(zh)
|
2015-04-17 |
2018-09-28 |
成都理工大学 |
作为PPAR-γ调节剂的氨基嘧啶衍生物
|
|
BR112017025986A2
(pt)
|
2015-06-02 |
2018-08-14 |
Pharmacyclics Llc |
inibidores de tirosina quinase de bruton.
|
|
RU2732405C2
(ru)
|
2015-07-02 |
2020-09-16 |
Тёрнинг Поинт Терапьютикс, Инк. |
Хиральные диарильные макроциклы в качестве модуляторов протеинкиназ
|
|
BR112018000297A2
(pt)
|
2015-07-06 |
2018-09-04 |
Tp Therapeutics Inc |
polimorfo de macrociclo de diarila
|
|
WO2017015367A1
(en)
|
2015-07-21 |
2017-01-26 |
Tp Therapeutics, Inc. |
Chiral diaryl macrocycles and uses thereof
|
|
EP3368039A1
(en)
|
2015-10-26 |
2018-09-05 |
The Regents of The University of Colorado, A Body Corporate |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
|
KR102782807B1
(ko)
*
|
2015-11-18 |
2025-03-14 |
브리스톨-마이어스 스큅 컴퍼니 |
Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 이미다조피리다진 화합물
|
|
EP3405464B1
(en)
|
2016-01-22 |
2019-12-04 |
Janssen Pharmaceutica NV |
New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors
|
|
AU2017302019A1
(en)
|
2016-07-28 |
2019-02-07 |
Turning Point Therapeutics, Inc. |
Macrocycle kinase inhibitors
|
|
US10836770B2
(en)
*
|
2016-10-07 |
2020-11-17 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
WO2018112027A1
(en)
|
2016-12-14 |
2018-06-21 |
Development Center For Biotechnology |
Antibody-drug conjugates and uses thereof
|
|
TWI808958B
(zh)
|
2017-01-25 |
2023-07-21 |
美商特普醫葯公司 |
涉及二芳基巨環化合物之組合療法
|
|
CN106866660B
(zh)
|
2017-02-15 |
2019-05-17 |
上海天马有机发光显示技术有限公司 |
电子传输材料、包含其的oled显示面板和电子设备
|
|
AU2018230737B2
(en)
|
2017-03-08 |
2022-09-22 |
Takeda Pharmaceutical Company Limited |
Tyk2 inhibitors, uses, and methods for production thereof
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
WO2018186366A1
(ja)
|
2017-04-03 |
2018-10-11 |
京都薬品工業株式会社 |
新規サイクリン依存性キナーゼ8及び/又は19阻害剤
|
|
WO2018234345A1
(en)
|
2017-06-21 |
2018-12-27 |
F. Hoffmann-La Roche Ag |
PYRAZOLO [1,5A] PYRIMIDINE DERIVATIVES AS MODULATORS OF IRAK4
|
|
PT3658148T
(pt)
|
2017-07-28 |
2024-08-26 |
Turning Point Therapeutics Inc |
Compostos macrocíclicos e utilizações dos mesmos
|
|
US10180422B1
(en)
|
2017-08-22 |
2019-01-15 |
Scripps Health |
Methods of treating a neuroendocrine tumor
|
|
KR102619444B1
(ko)
|
2017-08-23 |
2023-12-29 |
치아타이 티안큉 파마수티컬 그룹 주식회사 |
아미노피라졸 및 피리미딘을 함유하는 마크로사이클 및 그의 약학적 조성물 및 용도
|
|
WO2019049891A1
(ja)
|
2017-09-06 |
2019-03-14 |
小野薬品工業株式会社 |
Trk阻害剤とキナーゼ阻害剤の併用による癌治療方法
|
|
CA3080157A1
(en)
|
2017-10-26 |
2019-05-02 |
Array Biopharma Inc. |
Formulations of a macrocyclic trk kinase inhibitor
|
|
WO2019084499A1
(en)
|
2017-10-27 |
2019-05-02 |
Genea Biocells USA (Holdings), Inc. |
INHIBITORS OF DUX4 INDUCTION FOR REGULATION OF MUSCLE FUNCTION
|
|
CA3081790C
(en)
|
2017-11-10 |
2023-03-07 |
Angex Pharmaceutical, Inc. |
Macrocyclic compounds as trk kinase inhibitors and uses thereof
|
|
RS63787B1
(sr)
|
2017-12-19 |
2022-12-30 |
Turning Point Therapeutics Inc |
Makrociklična jedinjenja za lečenje bolesti
|
|
WO2019144885A1
(zh)
|
2018-01-23 |
2019-08-01 |
深圳市塔吉瑞生物医药有限公司 |
取代的吡唑并[1,5-a]嘧啶类的大环化合物
|
|
WO2019165967A1
(zh)
|
2018-02-28 |
2019-09-06 |
南京明德新药研发有限公司 |
吡唑并嘧啶衍生物及其用途
|
|
EP3773725A1
(en)
|
2018-03-29 |
2021-02-17 |
Loxo Oncology Inc. |
Treatment of trk-associated cancers
|
|
CN109053682B
(zh)
|
2018-07-27 |
2020-10-27 |
东南大学 |
一种tdo小分子抑制剂衍生物及其抗肿瘤偶联物和制备方法
|
|
RS66346B1
(sr)
|
2018-10-22 |
2025-01-31 |
Alumis Inc |
Inhibitori tyk2 i njihova upotreba
|
|
CA3126034A1
(en)
*
|
2019-01-23 |
2020-07-30 |
Nimbus Lakshmi, Inc. |
Tyk2 inhibitors and uses thereof
|
|
KR102943760B1
(ko)
|
2019-01-28 |
2026-03-26 |
장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 |
피리다진 유도체 억제제, 및 그의 제조 방법 및 용도
|
|
SG11202108619SA
(en)
|
2019-02-07 |
2021-09-29 |
Ventyx Biosciences Inc |
Tyk2 pseudokinase ligands
|
|
US20220177486A1
(en)
|
2019-03-11 |
2022-06-09 |
Esker Therapeutics, Inc. |
Tyk2 inhibitors and uses thereof
|
|
SG11202110523XA
(en)
|
2019-03-26 |
2021-10-28 |
Ventyx Biosciences Inc |
Tyk2 pseudokinase ligands
|
|
CN114929226B
(zh)
|
2019-11-08 |
2024-09-27 |
温缇克斯生物科学公司 |
Tyk2假激酶配体
|
|
EP4493281A1
(en)
*
|
2022-03-16 |
2025-01-22 |
Alumis Inc. |
Tyk2 inhibitors and uses thereof
|